SEC Comment Letter 0000000000-24-006917 to LifeMD, Inc. (LFMD)
LifeMD, Inc.
Date: June 17, 2024 · CIK: 0000948320 · Accession: 0000000000-24-006917
AI Filing Summary & Sentiment
File numbers found in text: 333-280033
Letter
United States securities and exchange commission logo June 17, 2024 Justin Schreiber Chief Executive Officer LifeMD, Inc. 236 Fifth Avenue, Suite 400 New York, NY 10001 Re:LifeMD, Inc. Registration Statement on Form S-3 Filed June 7, 2024 File No. 333-280033 Dear Justin Schreiber: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Cam Hoang, Esq.
Show Raw Text
United States securities and exchange commission logo
June 17, 2024
Justin Schreiber
Chief Executive Officer
LifeMD, Inc.
236 Fifth Avenue, Suite 400
New York, NY 10001
Re:LifeMD, Inc.
Registration Statement on Form S-3
Filed June 7, 2024
File No. 333-280033
Dear Justin Schreiber:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Cam Hoang, Esq.